Overview

The Development of Oral Nalbuphine Dosage Form

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate possible responses to pharmacokinetic properties for nalbuphine oral formulations in healthy volunteers.
Phase:
N/A
Details
Lead Sponsor:
Tri-Service General Hospital
Treatments:
Nalbuphine